What does PHARMACIE LECOMTE do?

PHARMACIE LECOMTE is a pharmacy in Bernissart. Public Limited, started on 15 November 1993, 1 establishment.

What is the address of PHARMACIE LECOMTE?

The registered office of PHARMACIE LECOMTE is located at Rue de Valenciennes(BER) 110, 7320 Bernissart.

Is PHARMACIE LECOMTE still active?

Yes. According to the CBE (30 October 2026) PHARMACIE LECOMTE is active, legal situation “Normale toestand”, started on 15 November 1993.

Is PHARMACIE LECOMTE registered on Peppol?

Yes, PHARMACIE LECOMTE is registered on the Peppol network with ID 0208:0451317442.

What is the enterprise number of PHARMACIE LECOMTE?

The enterprise number of PHARMACIE LECOMTE is BE0451317442.

When was PHARMACIE LECOMTE founded?

PHARMACIE LECOMTE was founded on 15 November 1993.

Who are the directors of PHARMACIE LECOMTE?

According to the 2025 annual accounts, the directors of PHARMACIE LECOMTE are: MEDISSART SRL, Xavier VAN QUICKELBERGHE.

Is PHARMACIE LECOMTE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 November 1993; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE LECOMTE make in 2025?

PHARMACIE LECOMTE posted a profit after taxes of € 84,384 in financial year 2025.

What is the revenue of PHARMACIE LECOMTE?

As a small company, PHARMACIE LECOMTE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 282,320.

How much does an employee at PHARMACIE LECOMTE earn?

The average wage cost per full-time employee at PHARMACIE LECOMTE was € 75,700 in 2025: staff costs of € 151,450 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE LECOMTE have?

According to the 2025 annual accounts, PHARMACIE LECOMTE has 2 full-time equivalents (FTE).

PHARMACIE LECOMTE (Public Limited) - Bernissart

Dossier PHARMACIE LECOMTE, printed on 30 October 2026 from databakkes.be/en/0451317442/pharmacie-lecomte. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2024.

Financials

Financial year 2025

PHARMACIE LECOMTE from Bernissart, company number BE0451317442, closed financial year 2025 with a result of € 84,384 after tax. For that financial year PHARMACIE LECOMTE recorded a gross margin of € 282,320 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 92,045 to € 84,384. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Growing

€ 1.2 million

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 84,384

▼ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 277,302

▲ 25% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.2 million.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 151,450

▲ 9% vs 2024

€ 75,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,796

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 50,553

▼ 13% vs 2024

€ 7,753 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 52,114

▼ 40% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 26,129

▼ 12% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 286,318 Gross margin 2022: € 286,318 First fiscal year in the series	€ 272,863 Gross margin 2023: € 272,863 ▼ 5% vs 2022 (€ 286,318) Unfavourable step	€ 279,906 Gross margin 2024: € 279,906 ▲ 3% vs 2023 (€ 272,863) Favourable step	€ 282,320 Gross margin 2025: € 282,320 ▲ 1% vs 2024 (€ 279,906) Favourable step	▲ 1%
Profit after taxes	€ 99,620 Profit after taxes 2022: € 99,620 First fiscal year in the series	€ 85,900 Profit after taxes 2023: € 85,900 ▼ 14% vs 2022 (€ 99,620) Unfavourable step	€ 92,045 Profit after taxes 2024: € 92,045 ▲ 7% vs 2023 (€ 85,900) Favourable step	€ 84,384 Profit after taxes 2025: € 84,384 ▼ 8% vs 2024 (€ 92,045) Unfavourable step	▼ 8%
Equity	€ 963,754 Equity 2022: € 963,754 First fiscal year in the series	€ 1,049,654 Equity 2023: € 1,049,654 ▲ 9% vs 2022 (€ 963,754) Favourable step	€ 1,141,699 Equity 2024: € 1,141,699 ▲ 9% vs 2023 (€ 1,049,654) Favourable step	€ 1,226,083 Equity 2025: € 1,226,083 ▲ 7% vs 2024 (€ 1,141,699) Favourable step	▲ 7%
Total debts	€ 232,729 Total debts 2022: € 232,729 First fiscal year in the series	€ 222,243 Total debts 2023: € 222,243 ▼ 5% vs 2022 (€ 232,729) Favourable step	€ 224,663 Total debts 2024: € 224,663 ▲ 1% vs 2023 (€ 222,243) Unfavourable step	€ 181,458 Total debts 2025: € 181,458 ▼ 19% vs 2024 (€ 224,663) Favourable step	▼ 19%
Cash	€ 722,667 Cash 2022: € 722,667 First fiscal year in the series	€ 787,855 Cash 2023: € 787,855 ▲ 9% vs 2022 (€ 722,667) Favourable step	€ 221,979 Cash 2024: € 221,979 ▼ 72% vs 2023 (€ 787,855) Unfavourable step	€ 277,302 Cash 2025: € 277,302 ▲ 25% vs 2024 (€ 221,979) Favourable step	▲ 25%
Land & buildings	€ 116,977 Land & buildings 2022: € 116,977 First fiscal year in the series	€ 109,651 Land & buildings 2023: € 109,651 ▼ 6% vs 2022 (€ 116,977) Unchanged	€ 102,326 Land & buildings 2024: € 102,326 ▼ 7% vs 2023 (€ 109,651) Unchanged	€ 95,000 Land & buildings 2025: € 95,000 ▼ 7% vs 2024 (€ 102,326) Unchanged	▼ 7%
Retained profit	€ 901,754 Retained profit 2022: € 901,754 First fiscal year in the series	€ 987,654 Retained profit 2023: € 987,654 ▲ 10% vs 2022 (€ 901,754) Favourable step	€ 1,079,699 Retained profit 2024: € 1,079,699 ▲ 9% vs 2023 (€ 987,654) Favourable step	€ 1,164,083 Retained profit 2025: € 1,164,083 ▲ 8% vs 2024 (€ 1,079,699) Favourable step	▲ 8%
Bank debt	€ 73,930 Bank debt 2022: € 73,930 First fiscal year in the series	€ 67,188 Bank debt 2023: € 67,188 ▼ 9% vs 2022 (€ 73,930) Favourable step	€ 57,966 Bank debt 2024: € 57,966 ▼ 14% vs 2023 (€ 67,188) Favourable step	€ 50,553 Bank debt 2025: € 50,553 ▼ 13% vs 2024 (€ 57,966) Favourable step	▼ 13%
Balance sheet total	€ 1,196,483 Balance sheet total 2022: € 1,196,483 First fiscal year in the series	€ 1,271,897 Balance sheet total 2023: € 1,271,897 ▲ 6% vs 2022 (€ 1,196,483) Unchanged	€ 1,366,362 Balance sheet total 2024: € 1,366,362 ▲ 7% vs 2023 (€ 1,271,897) Unchanged	€ 1,407,541 Balance sheet total 2025: € 1,407,541 ▲ 3% vs 2024 (€ 1,366,362) Unchanged	▲ 3%
Employees (FTE)	2 Employees (FTE) 2022: 2 First fiscal year in the series	2 Employees (FTE) 2023: 2 Unchanged (2) Unchanged	2 Employees (FTE) 2024: 2 Unchanged (2) Unchanged	2 Employees (FTE) 2025: 2 Unchanged (2) Unchanged

Key figures of PHARMACIE LECOMTE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE LECOMTE?

What happened at PHARMACIE LECOMTE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 MEDISSART SRL stepped down as director. NBB
2029 Xavier VAN QUICKELBERGHE stepped down as director. NBB
Jun 29, 2026 New annual accounts for financial year 2025: profit of € 84,384 (▼ 8% vs 2024). Source: NBB ↗
2023 MEDISSART SRL became a director. NBB
2023 Xavier VAN QUICKELBERGHE became a director. NBB
Dec 21, 1993 New establishment in Bernissart. KBO
Nov 15, 1993 Start of the company according to the CBE. KBO

In short

From € 99,620 profit in 2022 to € 84,384 profit in 2025.

Paid € 129,961 in corporate taxes since 2022.

Best year ever: 2022, with € 99,620 profit.

On average € 141,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

MEDISSART

Xavier VAN QUICKELBERGHE

PHARMACIE LECOMTE

The shares are held by MEDISSART and Xavier VAN QUICKELBERGHE.

Directors

According to the 2025 annual accounts

MEDISSART SRL

Director · represented by Bénédicte CALONNE

since 2023 · until 2029

Xavier VAN QUICKELBERGHE

Managing director

Is a shareholder

Also active at: MEDISSART

since 2023 · until 2029

Shareholders

MEDISSART

Xavier VAN QUICKELBERGHE · director

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Valenciennes(BER) 110

7320 Bernissart

2.064.697.656

Rue de Valenciennes(BER) 85

7320 Bernissart

Active since 21 December 1993

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

MEDISSART same network

€ 112,144 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0451.317.442

VAT number

BE 0451.317.442

Registered office

Rue de Valenciennes(BER) 110, 7320 Bernissart

Names & denominations

PHARMACIE LECOMTE

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

15 November 1993

Peppol

Active · Active since 19 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE LECOMTE

Warning lights

Financials

What happened to PHARMACIE LECOMTE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions